Sleep Apnea
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Insufficient Sleep and Sleep Deprivation
Sleep-Wake Cycles
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 3, 2025

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
John Ciriello1, Jason M Moreau1, Monica M Caverson1
1Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.
Chronic intermittent hypoxia (CIH), linked to sleep apnea, may cause leptin resistance and weight gain. This study in rats shows CIH impairs leptin signaling, leading to increased body weight and reduced activity.
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: